Predicting related factors of immunological response to hepatitis B vaccine in hemodialysis patients based on integration of decision tree classification and logistic regression

References

• WHO. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. World Health Organization; 2015.
   Google Scholar
• GuoLiang X, ChongBai L, HuiLin C, ShengLi B, MeiYun Z, ChongAo S, JunHua N, XiaoQui Q. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992. Inter Hepatol Commun. 1996;5:62–73. doi:10.1016/0928-4346(96)00282-4.
   Web of Science ®Google Scholar
• Xiaofeng L, Shengli B, Weizhong Y, Longde W, Gang C, Fuqiang C, Yong Z, Jianhua L, Xiaohong G, Yuansheng C, et al. Epidemiological serosurvey of hepatitis B in China–declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009;27(47):6550–57. doi:10.1016/j.vaccine.2009.08.048.
   PubMed Web of Science ®Google Scholar
• Collaborators PO. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3:383–403.
   PubMed Web of Science ®Google Scholar
• Sari F, Taskapan H. Good response to HBsAg vaccine in dialysis patients is associated with high CD4+/CD8+ ratio. Int Urol Nephrol. 2012;44(5):1501–06. doi:10.1007/s11255-011-0043-6.
   PubMed Web of Science ®Google Scholar
• Vaziri ND, Pahl MV, Crum A, Norris K. Effect of uremia on structure and function of immune system. J Ren Nutr. 2012;22(1):149–56. doi:10.1053/j.jrn.2011.10.020.
   PubMed Web of Science ®Google Scholar
• Khalid AS, Sabry A, Zakaria AH, Ismail M. Factors affecting response to hepatitis B vaccine among hemodialysis patients in a large Saudi hemodialysis center. Saudi J Kidney Dis Trans Off Pub Saudi Center Organ Trans Saudi Arabia. 2014;25(1):185–91. doi:10.4103/1319-2442.124572.
   PubMedGoogle Scholar
• Tong NKC, Beran J, Kee SA, Miguel JL, Sánchez C, Bayas JM, Vilella A, Juanes JR, Arrazola P, Calbo-Torrecillas F, et al. Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients. Kidney Int. 2005;68(5):2298–303. doi:10.1111/j.1523-1755.2005.00689.x.
   PubMed Web of Science ®Google Scholar
• Jiahui S, Canqing Y, Yu G, Zheng B, Chenxi Q, Ling Y, Yiping C, Li Y, Hui L, Jian L, et al. Chronic hepatitis B virus infection and risk of chronic kidney disease: a population-based prospective cohort study of 0.5 million Chinese adults. BMC Med. 2018;16(1):93. doi:10.1186/s12916-018-1084-9.
   PubMed Web of Science ®Google Scholar
• Kara IH, Yilmaz ME, Suner A, Kadiroglu AK, Isikoglu B. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients. Vaccine. 2004;22(29–30):3963–67. doi:10.1016/j.vaccine.2004.04.001.
   PubMed Web of Science ®Google Scholar
• Fabrizi F, Ganeshan SV, Dixit V, Martin P. Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease. Aliment Pharmacol Ther. 2006;24(5):789–96. doi:10.1111/j.1365-2036.2006.03035.x.
   PubMed Web of Science ®Google Scholar
• Saade F, Honda-Okubo Y, Trec S, Petrovsky N. A novel hepatitis B vaccine containing Advax, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing. Vaccine. 2013;31(15):1999–2007. doi:10.1016/j.vaccine.2012.12.077.
   PubMed Web of Science ®Google Scholar
• Ramezani A, Eslamifar A, Banifazl M, Ahmadi F, Maziar S, Razeghi E, Kalantar E, Amirkhani A, Aghakhani A. Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients. Int J Clin Pract. 2009;63(3):394–97. doi:10.1111/j.1742-1241.2007.01470.x.
   PubMed Web of Science ®Google Scholar
• Fabrizi F, Dixit V, Messa P, Martin P. Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: a meta-analysis of randomized trials. J Viral Hepat. 2011;18(10):730–37. doi:10.1111/j.1365-2893.2010.01354.x.
   PubMed Web of Science ®Google Scholar
• Kaiming C, Manching L, Chibon L, Cheukchun S, Philipkam-Tao L. Antibody Response to Hepatitis B Vaccine in End-Stage Renal Disease Patients. Nephron Clin Pract. 2006;103(3):c89–93. doi:10.1159/000092016.
   PubMedGoogle Scholar
• Cordova E, Miglia I, Festuccia F, Sarlo MG, Scornavacca G, Punzo G, Mene P, Fofi C. Hepatitis B vaccination in haemodialysis patients: an underestimated problem. Factors influencing immune responses in ten years of observation in an Italian haemodialysis centre and literature review. Ann Ig. 2017;29(1):27–37. doi:10.7416/ai.2017.2129.
   PubMed Web of Science ®Google Scholar
• Saracoglu A, Ozen H. Estimation of traffic incident duration: a comparative study of decision tree models. Arab J Sci Eng. 2020;45(10):8099–110. doi:10.1007/s13369-020-04615-2.
   Web of Science ®Google Scholar
• Gao L, Smielewski P, Li P, Czosnyka M, Ercole A. Signal information prediction of mortality identifies unique patient subsets after severe traumatic brain injury: a decision-tree analysis approach. J Neurotrauma. 2020;37(7):1011–19. doi:10.1089/neu.2019.6631.
   PubMed Web of Science ®Google Scholar
• Jian S, Liping L, Yequn C. The role of Decision tree model and Logistic regression in injury influencing factors analysis. Chin J Dis Control Preven. 2015;19:185–89.
   Google Scholar
• Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W. Hepatitis B vaccine in patients receiving hemodialysis: immunogenicity and efficacy. N Engl J Med. 1984;311(8):496–501. doi:10.1056/NEJM198408233110803.
   PubMed Web of Science ®Google Scholar
• Campos Nizama J. Humoral immunity level and factors associated with the response to the vaccine against the hepatitis B virus in health personnel of the case-essalud national hospital, arequipa september 1995-march 2002. Rev Gastroenterol Peru. 2005;25:141–49.
   PubMedGoogle Scholar
• Sopori ML, Kozak W, Savage SM, Geng Y, Soszynski D, Kluger MJ, Perryman EK, Snow GE. Effect of nicotine on the immune system: possible regulation of immune responses by central and peripheral mechanisms. Psychoneuroendocrinology. 1998;23(2):189–204. doi:10.1016/S0306-4530(97)00076-0.
   PubMed Web of Science ®Google Scholar
• Scharf P, Da Rocha GHO, Sandri S, Heluany CS, Pedreira Filho WR, Farsky SHP. Immunotoxic mechanisms of cigarette smoke and heat-not-burn tobacco vapor on Jurkat T cell functions. Environ Pollut. 2020;268(Pt B):115863. doi:10.1016/j.envpol.2020.115863.
   PubMed Web of Science ®Google Scholar
• Sit D, Esen B, Atay AE, Kayabasi H. Is hemodialysis a reason for unresponsiveness to hepatitis B vaccine? Hepatitis B virus and dialysis therapy. World J Hepatol. 2015;7(5):761–68. doi:10.4254/wjh.v7.i5.761.
   PubMed Web of Science ®Google Scholar
• Zhimao C, Bo H. Study on permeability of dialysis membranes to macromolecular straight-chain compounds. Chin Pharm J. 2000;35:120.
   Google Scholar
• Yanlin S, Xinjie W, Liaolin L. Causes of rapid decrease of hepatitis B surface antibody titer in hemodialysis patients. J Clin Intern Med. 2016;33:277.
   Google Scholar
• Yongliang F, Xiaohong S, Jing S, Linying G, Guangming L, Yanpeng C, Minghu P, Li C, Jun W, Xuxia G, et al. Immunogenicity, antibody persistence, and safety of the 60 µg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trial. Expert Rev Vaccines. 2017;16(10):1045–52. doi:10.1080/14760584.2017.1367667.
   PubMed Web of Science ®Google Scholar
• Aziz A, Aziz S, Li DS, Murphy L, Leone N, Kennedy M, Dhillon S, Van Thiel DH. Efficacy of repeated high-dose hepatitis B vaccine (80 micron) in patients with chronic liver disease. J Viral Hepat. 2006;13(4):217–21. doi:10.1111/j.1365-2893.2005.00674.x.
   PubMed Web of Science ®Google Scholar
• Dhillon S, Moore C, Li SD, Aziz A, Kakar A, Dosanjh A, Beesla A, Murphy L, Van Thiel DH. Efficacy of High-Dose Intra-dermal Hepatitis B Virus Vaccine in Previous Vaccination Non-responders with Chronic Liver Disease. Dig Dis Sci. 2012;57(1):215–20. doi:10.1007/s10620-011-1996-0.
   PubMed Web of Science ®Google Scholar
• Oguz Y, Doganci L, Vural A. Seroconversion rates of two different doses of hepatitis B vaccine in Turkish haemodialysis patients. Cent Eur J Public Health. 2001;9:44–45.
   PubMedGoogle Scholar
• Cuiyu W, Jinghua S, Bei Z, Steven L, Rongbin Y, Jianqing W, Weihong Z. Hepatitis B virus infection and related factors in hemodialysis patients in China - systematic review and meta-analysis. Ren Fail. 2010;32(10):1255–64. doi:10.3109/0886022X.2010.517354.
   PubMed Web of Science ®Google Scholar
• Sabry R, Mohamed ZAZ, Abdallah AM. Relationship between Th1 and Th2 cytokine serum levels and immune response to Hepatitis B vaccination among Egyptian health care workers. J Immunoassay Immunochem. 2018;39(5):496–508. doi:10.1080/15321819.2018.1509871.
   PubMedGoogle Scholar
• Pileggi C, Papadopoli R, Bianco A, Pavia M. Hepatitis B vaccine and the need for a booster dose after primary vaccination. Vaccine. 2017;35(46):6302–07. doi:10.1016/j.vaccine.2017.09.076.
   PubMed Web of Science ®Google Scholar
• Xiaofeng L, Fang J, Fuchu Q, Weihong W. Molecular characterization of occult HBV infection among subjects with single positive HBcAb. Chin J Health Lab Tec. 2020;30:578–80.
   Google Scholar
• Soi V, Soman S. Preventing hepatitis b in the dialysis unit. Adv Chronic Kidney Dis. 2019;26(3):179–84. doi:10.1053/j.ackd.2019.03.003.
   PubMed Web of Science ®Google Scholar